Adolescents with Atopic Dermatitis experience greater burden of bullying Isra Zaman16 Nov 2023 9:15 AM ISTAtopic dermatitis (AD) is a skin condition characterized by recurrent eczematous lesions and intense pruritus. Such patients often experience physical...
FDA approved Bimzelx for plaque psoriasis now commercially available Dr. Kamal Kant Kohli15 Nov 2023 7:15 PM ISTIn October US Food and Drug Administration had approved for plaque psoriasis. Bimzelx, an IL-17A and IL-17F inhibitor is now commercially available...
Acupuncture may offer limited relief to patients with chronic spontaneous urticaria Dr. Kamal Kant Kohli14 Nov 2023 9:15 PM ISTA randomized controlled trial that included more than 300 people diagnosed with chronic spontaneous urticaria (CSU), or hives, found that acupuncture...
Jubilant Radiopharma business receives ANDA approval for Technetium Sulfur Colloid Injection Ruchika Sharma14 Nov 2023 12:30 PM ISTNoida: Jubilant Pharmova Limited’s wholly owned subsidiary Jubilant Draximage Inc ('Company') has announced that it has received approval from...
Adolescents with Atopic Dermatitis experience Greater Burden of bullying: JAMA. Aditi14 Nov 2023 8:30 AM ISTAtopic dermatitis (AD) is a skin condition characterized by recurrent eczematous lesions and intense pruritus. Such patients often experience physical...
Tildrakizumab Effective option for patients with Psoriasis and Psoriatic Arthritis Jacinthlyn Sylvia13 Nov 2023 4:45 AM ISTA recent study delved into the nuanced realm of psoriasis management, specifically investigating the potential benefits of tildrakizumab and its role...
Topical sirolimus gel clinically effective for systemic rare vascular malformations Medha Baranwal11 Nov 2023 9:30 AM ISTJapan: A recent pilot study has claimed 0.2% sirolimus gel to be safe for venous and capillary malformations and more effective for early active...
Extra-Strength Jeuveau achieves positive outcomes for treatment of glabellar lines in adults for up to 6 months Dr Riya Dave11 Nov 2023 9:15 AM ISTEvolus, Inc. recently revealed results from a Phase 2 clinical study showcasing the efficacy of the "extra-strength" 40U dose of Jeuveau in extending...
Researchers identify incidence and risk factors for new-onset interstitial lung disease in systemic sclerosis Isra Zaman11 Nov 2023 9:00 AM ISTNew research at ACR Convergence 2023, the American College of Rheumatology's (ACR) annual meeting, reports the incidence and risk factors for...
Study finds JAK inhibitors and tocilizumab effective in VEXAS syndrome Isra Zaman10 Nov 2023 9:30 AM ISTA recent study presented at ACR Convergence 2023 has offered newfound hope for individuals battling VEXAS syndrome, a rare and often lethal autoimmune...
Dermoscopy facilitates early diagnosis of acral lentiginous melanomas and reduces unnecessary biopsies Medha Baranwal9 Nov 2023 8:00 PM ISTUSA: A recent review published in Dermatologic Surgery has promoted dermoscopy use to help facilitate early diagnosis of acral lentiginous melanomas...
Low dose oral Minoxidil reveals favorable safety profile in patients with hypertension or arrhythmia Dr. Shravani Dali9 Nov 2023 10:00 AM ISTLow Dose Oral Minoxidil found safe among patients with hypertension or arrhythmia suggests a new study published in the Actas...
